Once-daily intranasal corticosteroids for allergic rhinitis. Examining Treatment issues.
Knudtson
Mary
M
Department of Family Medicine, University of California, Irvine, USA.
D000281:Administration, Intranasal; D000730:Androstadienes / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001507:Beclomethasone / Q000008:administration & dosage; D019819:Budesonide / Q000008:administration & dosage; D002908:Chronic Disease; D003937:Diagnosis, Differential; D004334:Drug Administration Schedule; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000031:analogs & derivatives; D000068298:Fluticasone; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D009722:Nurse Practitioners; D024802:Nurse's Role; D017060:Patient Satisfaction; D012221:Rhinitis, Allergic, Perennial / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D012720:Severity of Illness Index; D014221:Triamcinolone / Q000008:administration & dosage
D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D005446:Fluocinolone Acetonide; D014221:Triamcinolone; D019819:Budesonide; C007734:flunisolide; D000068298:Fluticasone; D001507:Beclomethasone